宝馨科技（002514）被证监会立案调查，受损投资者可准备索赔

Core Viewpoint - Jiangsu Baoxin Technology Co., Ltd. (stock code: 002514) has received a notice from the China Securities Regulatory Commission (CSRC) regarding an investigation for suspected violations of information disclosure laws [1][6]. Group 1: Investigation Details - The CSRC has decided to initiate an investigation against the company and its actual controller, Ma Wei, due to alleged violations of the Securities Law and the Administrative Penalty Law of the People's Republic of China [1][6]. - Baoxin Technology stated that during the investigation, it will actively cooperate with the CSRC and comply with regulatory disclosure requirements [2][6]. Group 2: Impact on Operations - The company emphasized that Ma Wei does not hold any position within the company and that all production and operational activities are proceeding normally, indicating that the investigation has not affected the company's regular operations [2][6]. Group 3: Investor Rights and Compensation - Investors who suffered losses due to the alleged violations have the right to seek compensation. According to the Securities Law and related judicial interpretations, investors can file lawsuits for damages caused by false statements [2][6]. - Preliminary compensation conditions state that investors who purchased Baoxin Technology shares before or on January 30, 2026, and still hold them after the market close on that date, may prepare for compensation claims [7]. Group 4: Required Documentation for Claims - Investors need to prepare the following documents for compensation claims: 1. Original transaction statements for Baoxin Technology shares, stamped by the brokerage [7]. 2. A photocopy of the investor's ID card [8]. 3. An original securities account information query form, also stamped by the brokerage [9].